✦ LIBER ✦

Impact of a chemoresponse assay on treatment costs for recurrent ovarian cancer

✍ Scribed by Laura J. Havrilesky; Thomas C. Krivak; John W. Mucenski; Evan R. Myers

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A prospective study evaluating the clini

✍ Rutherford, Thomas; Orr, James; Grendys, Edward; Edwards, Robert; Krivak, Thomas 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 537 KB

A prospective study evaluating the clini

✍ Rutherford, T.; Orr, J.; Grendys, E.; Edwards, R.; Krivak, T.; Holloway, R.; Moo 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 45 KB

A chemoresponse assay for prediction of

✍ Krivak, Thomas C.; Lele, Shashikant; Richard, Scott; Secord, Angeles Alvarez; Le 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 718 KB

A chemoresponse assay for prediction of

✍ Krivak, T.; Secord, A. Alvarez; Richard, S.; Leath, C.; Moore, R.; Coleman, R.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Cost-Effectiveness Of Prophylaxis Treatm

✍ Fust, K.; Li, X.; Maschio, M.; Barron, R.; Weinstein, M.C.; Parthan, A.; Walli-A 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Cost-effectiveness of prophylaxis treatm

✍ Fust, Kelly; Li, Xiaoyan; Maschio, Michael; Barron, Richard; Weinstein, Milton C 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 457 KB